Hamilton News

Hamilton advises Karo Pharma AB in connection with rights issue

Hamilton acts as le­gal ad­vis­er to Karo Pharma AB in con­nec­tion with its MSEK 374 rights is­sue. Karo Pharma’s shares are list­ed on Nasdaq Stockholm, Mid Cap.

Karo Pharma is a spe­cial­ty phar­ma com­pa­ny that de­vel­ops and mar­kets prod­ucts for phar­ma­cies and di­rect­ly to the health care sec­tor.

Hamilton’s team in­cludes

Charles Andersson, Emil Hedberg, Björn Möller, Carl Magnusson and Sofi Lissman.